What is selinexor? An innovative oral therapy for specific cancers
•
4 min read
Selinexor (Xpovio), a first-in-class oral selective inhibitor of nuclear export (SINE), was granted accelerated FDA approval in 2019 for the treatment of certain hematological malignancies. But what is selinexor, and how does this innovative drug fight cancer cells?
